drug

EN3342

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Endo USA Inc., a Keenova Therapeutics Company
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)
SchizophreniaSchizophrenia

Trials

1
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
NCT01774435Phase 1Completed

KOLs & investigators

1
Robert Litman, MDKOL score 9

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Endo USA Inc., a Keenova Therapeutics Company
company
trial
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
PHASE1
trial
indication
Schizophrenia
indication
Schizophrenia
indication
KOL
Robert Litman, MD
KOL score 9
person